Evidence map›Paper›PMID 28688029›Full record

ArticleAIDS and behavior2018

Patterns of a Rectal Microbicide Placebo Gel Use in a Preparatory Stage for a Phase I Trial Among Young Men Who Have Sex with Men.

José A Bauermeister, R Giguere, C S Leu, C Dolezal, I Febo, R D Cranston, K Mayer, I McGowan, A Carballo-Diéguez

Abstract read
In one paragraph

Article in AIDS and behavior, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

José A BauermeisterSchool of Nursing, University of Pennsylvania, 418 Curie Blvd, Suite 402, Philadelphia, PA, 19109, USA. bjose@upenn.edu.
R GiguereHIV Center for Clinical and Behavioral Studies, Columbia University and NY State Psychiatric Institute, New York, USA.
C S LeuHIV Center for Clinical and Behavioral Studies, Columbia University and NY State Psychiatric Institute, New York, USA.
C DolezalHIV Center for Clinical and Behavioral Studies, Columbia University and NY State Psychiatric Institute, New York, USA.
I FeboDepartment of Pediatrics, Gama Project, University of Puerto Rico Medical Sciences Campus, San Juan, PR, USA.
R D CranstonDivision of Infectious Diseases, School of Medicine, University of Pittsburgh, Pittsburgh, USA.
K MayerFenway Health, Fenway Institute, Boston, USA.
I McGowanDivision of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh School of Medicine, Pittsburgh, USA.
A Carballo-DiéguezHIV Center for Clinical and Behavioral Studies, Columbia University and NY State Psychiatric Institute, New York, USA.

Funding

The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Claude Ann Mellins · 2003 to 2026
$48.2M
Microbicide Safety and Acceptability in Young MenR01HD059533 · NICHD · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI MCGOWAN, IAN MICHAEL · 2009 to 2012
$6.6M
NICHD NIH HHS R01 HD059533NIMH NIH HHS P30 MH043520
6 · The paper itself

Abstract

We examined young gay, bisexual, and other men who have sex with men's (YGBMSM) usage patterns of a pre-coital, applicator-administered rectal placebo gel. An ethnically diverse sample of 94 YGBMSM (aged 18-30 years) were asked to insert hydroxyethylcellulose placebo gel rectally before receptive anal intercourse (RAI) and report their gel use through an interactive voice response system (IVRS) across 12 weeks. We used trajectory analyses to characterize participants' use of the rectal gel over the 12 weeks, and examine whether these trajectories varied based on participants' sociodemographic characteristics, sexual behaviors, application and insertion behaviors, and experiences using the placebo gel. A cubic model was the best fit for these longitudinal data, with two distinct trajectories of gel use observed. The first trajectory ('High with Varying Gel Use per Week') represented YGBMSM (N = 38; 40.3%) who reported using the rectal gel on several occasions per week. The second trajectory ('Low and Consistent Gel Use per Week') represented participants (N = 56; 59.7%) who reported a consistent average use of one gel per week. Participants in the High with Varying Gel Use Trajectory reported trying out a greater number of positions when inserting the gel across the 12-weeks than peers in the Low and Consistent Gel Use Trajectory. YGBMSM reporting more RAI occasions during the trial were more likely be present in the High with Varying Gel Use Trajectory than peers in the Low and Consistent Gel Use Trajectory. Future research examining how to facilitate gel application and adherence among YGBMSM is merited.

Indexed as

BisexualityHomosexuality, MalePatient Acceptance of Health CarePersonal SatisfactionSexual BehaviorAdministration, RectalAdolescentAdultAnti-Infective AgentsClinical Trials, Phase I as TopicCoitusEthnicityGelsHIV InfectionsHumansMaleAnti-Infective AgentsGelsAcceptabilityApplicator satisfactionGayHIV/AIDSPreventionRectal microbicide

Identifiers

PMID28688029
PMCPMC5756684

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.